Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
A Relationship to Financial Investing?
Courtesy: www.CertifiedMedicalPlanner.org
By Dr. David E. Marcinko MBA CMP
The basic reproduction number R0, [r nought) of an infection is the number of cases it generates on average over the course of its infectious period, in an otherwise uninfected population.
The metric determines whether or not a disease can spread through a population. The root concept is traced to Alfred Lotka and Ronald Ross, but its first application was by George MacDonald in 1952, with malaria.
LINK: https://www.healthline.com/health/r-nought-reproduction-number
FORMULA: When
R0 < 1
the infection will die out in the long run. But if
R0 > 1
the infection will be able to spread in a population.
LINK: https://wwwnc.cdc.gov/eid/article/25/1/17-1901_article
ASSESSMENT: Generally, the larger the value of R0, the harder it is to control the epidemic. In the past week, Corona virus estimates ranged from 1.4 to 5.5. The World Health Organization (WHO) range was 1.4 and 2.5. In comparison, seasonal flu affects millions each year but has an R0 of just 1.3. The R0 rate for measles ranges from 12 to 18.
***
***
Your thoughts are appreciated.
BUSINESS, FINANCE AND INSURANCE TEXTS FOR DOCTORS:
THANK YOU
8
***
Share this:
Filed under: Health Economics, Investing, Portfolio Management, Research & Development | Tagged: corona virus, Epidemiology, r-NOUGHT, Ro, WHO | Leave a comment »
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 